Innate immunity drives the initiation of a murine model of primary biliary cirrhosis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chang, Chao Hsuan ^a   Chen, Ying Chun ^a   Zhang, Weici ^b   Leung, Patrick S C ^b   Gershwin, M Eric ^b   Chuang, Ya Hui ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA DEXTRO GALACTOPYRANOSYL) N TETRACOSANOYL 2 AMINO 1,3,4 NONANETRIOL; ALPHA GALACTOSYLCERAMIDE; CHEMICAL COMPOUND; GAMMA INTERFERON; MITOCHONDRION ANTIBODY; UNCLASSIFIED DRUG; ALPHA-GALACTOSYLCERAMIDE; CD1D ANTIGEN; GALACTOSYLCERAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD-1 MOUSE; CELL COUNT; CELL INFILTRATION; CHOLANGITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; HEPATITIS; HISTOPATHOLOGY; INNATE IMMUNITY; INVARIANT NATURAL KILLER T CELL; LIVER FIBROSIS; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; T LYMPHOCYTE ACTIVATION; ANIMAL; BILIARY CIRRHOSIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE;

MURINAE; MUS;

ANIMALS; ANTIGENS, CD1D; DISEASE MODELS, ANIMAL; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS;

EID: 84926282957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121320     Document Type: Article

References (48)

1. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, Kyparissoudis K, et al. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 2009; 31: 47-59. doi: 10.1016/j.immuni.2009.04.018 PMID: 19592275
2. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000; 191: 1895-1903. PMID: 10839805
3. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013; 13: 101-117. doi: 10.1038/nri3369 PMID: 23334244
4. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114: 1379-1388. PMID: 15545985
5. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004; 4: 231-237. PMID: 15039760
6. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877-900. PMID: 15771592
7. Cerundolo V, Silk JD, Masri SH, Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 2009; 9: 28-38. doi: 10.1038/nri2451 PMID: 19079136
8. Cullen R, Germanov E, Shimaoka T, Johnston B. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation. J Immunol 2009; 183: 5807-5815. doi: 10.4049/jimmunol.0803520 PMID: 19812206
9. Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum 2004; 50: 305-313. PMID: 14730629
10. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413: 531-534. PMID: 11586362
11. Mizuno M, Masumura M, Tomi C, Chiba A, Oki S, Yamamura T, et al. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun 2004; 23: 293-300. PMID: 15571923
12. Walker KM, Rytelewski M, Mazzuca DM, Meilleur SA, Mannik LA, Yue D, et al. Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist. Immunol Cell Biol 2012; 90: 630-639. doi: 10.1038/icb.2011.78 PMID: 21912419
13. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 2008; 47: 737-745. PMID: 18098322
14. He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006; 239: 1-13. PMID: 16765923
15. Chuang YH, Ridgway WM, Ueno Y, Gershwin ME. Animal models of primary biliary cirrhosis. Clin Liver Dis 2008; 12: 333-347; ix. doi: 10.1016/j.cld.2008.02.011 PMID: 18456184
16. Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N, et al. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 1999; 19: 422-427. PMID: 10634216
17. Kawata K, Tsuda M, Yang GX, Zhang W, Tanaka H, Tsuneyama K, et al. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. PLoS One 2013; 8: e74225. doi: 10.1371/journal.pone.0074225 PMID: 24040208
18. Wu SJ, Yang YH, Tsuneyama K, Leung PS, Illarionov P, Gershwin ME, et al. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011; 53: 915-925. doi: 10.1002/hep.24113 PMID: 21374662
19. Chang CH, Chen YC, Yu YH, Tao MH, Leung PS, Ansari AA, et al. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol 2014; 177: 373-380. doi: 10.1111/cei.12298 PMID: 24547942
20. Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM, et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 2008; 47: 571-580. PMID: 18098320
21. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-3531. PMID: 3571977
22. Huang W, Kachapati K, Adams D, Wu Y, Leung PS, Yang GX, et al. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun 2014; 50: 123-134. doi: 10.1016/j.jaut.2014.01.034 PMID: 24556277
23. Liaskou E, Hirschfield GM, Gershwin ME. Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol 2014; 36: 553-568. doi: 10.1007/s00281-014-0439-3 PMID: 25082647
24. Lleo A, Zhang W, McDonald WH, Seeley EH, Leung PS, Coppel RL, et al. Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 2014; 60: 1314-1323. doi: 10.1002/hep.27230 PMID: 24841946
25. Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP, et al. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014; 59: 1944-1953. doi: 10.1002/hep.26979 PMID: 24375552
26. Yao Y, Yang W, Yang YQ, Ma HD, Lu FT, Li L, et al. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-/-) mice. J Autoimmun 2014; 51: 99-108. doi: 10.1016/j.jaut.2014.02.009 PMID: 24651036
27. Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL, et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014; 60: 1708-1716. doi: 10.1002/hep.27313 PMID: 25043065
28. Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P, et al. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 2013; 57: 708-715. doi: 10.1002/hep.26067 PMID: 22996325
29. Kawata K, Yang GX, Ando Y, Tanaka H, Zhang W, Kobayashi Y, et al. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 2013; 58: 1094-1104. doi: 10.1002/hep.26418 PMID: 23532950
30. Viale R, Ware R, Maricic I, Chaturvedi V, Kumar V. NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation. Curr Immunol Rev 2012; 8: 287-296. PMID: 25288922
31. Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem 2012; 287: 24378-24386. doi: 10.1074/jbc.M112.371807 PMID: 22645141
32. Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, Trivedi O, et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008; 3: 304-315. doi: 10.1016/j.chom.2008.03.009 PMID: 18474357
33. Ortaldo JR, Young HA, Winkler-Pickett RT, Bere EW Jr., Murphy WJ, Wiltrout RH. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol 2004; 172: 943-953. PMID: 14707067
34. Zhang W, Moritoki Y, Tsuneyama K, Yang GX, Ilan Y, Lian ZX, et al. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis. Clin Exp Immunol 2009; 157: 359-364. doi: 10.1111/j.1365-2249.2009.03971.x PMID: 19664143
35. Lee IF, van den Elzen P, Tan R, Priatel JJ. NKT cells are required for complete Freund's adjuvant-mediated protection from autoimmune diabetes. J Immunol 2011; 187: 2898-2904. doi: 10.4049/jimmunol.1002551 PMID: 21844383
36. Zeng SG, Ghnewa YG, O'Reilly VP, Lyons VG, Atzberger A, Hogan AE, et al. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J Immunol 2013; 191: 1666-1676. doi: 10.4049/jimmunol.1202223 PMID: 23851681
37. Detre C, Keszei M, Garrido-Mesa N, Kis-Toth K, Castro W, Agyemang AF, et al. SAP expression in invariant NKT cells is required for cognate help to support B-cell responses. Blood 2012; 120: 122-129. doi: 10.1182/blood-2011-11-395913 PMID: 22613797
38. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31: 252-256. doi: 10.1016/j.jaut.2008.04.017 PMID: 18502610
39. Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25: 791-796. PMID: 9096578
40. Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009; 32: 43-51. doi: 10.1016/j.jaut.2008.11.001 PMID: 19101114
41. Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, Jiang T, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009; 156: 217-225. doi: 10.1111/j.1365-2249.2009.03898.x PMID: 19302244
42. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157: 261-270. doi: 10.1111/j.1365-2249.2009.03947.x PMID: 19604266
43. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996; 80: 311-320. PMID: 8811053
44. Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL, et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 2006; 26: 232-240. PMID: 16730427
45. Ambrosini YM, Yang GX, Zhang W, Tsuda M, Shu S, Tsuneyama K, et al. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis. Clin Exp Immunol 2011; 166: 110-120. doi: 10.1111/j.1365-2249.2011.04453.x PMID: 21910728
46. Okada C, Akbar SM, Horiike N, Onji M. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int 2005; 25: 595-603. PMID: 15910497
47. Shimoda S, Harada K, Niiro H, Shirabe K, Taketomi A, Maehara Y, et al. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology 2011; 53: 1270-1281. doi: 10.1002/hep.24194 PMID: 21400555
48. Shimoda S, Tsuneyama K, Kikuchi K, Harada K, Nakanuma Y, Nakamura M, et al. The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis. Clin Exp Immunol 2012; 168: 279-284. doi: 10.1111/j.1365-2249.2012.04581.x PMID: 22519590